New spine implants aim to improve fusion in back surgery

NCT ID NCT06704919

Recruiting now Disease control Sponsor: Nitin Agarwal Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing two medical devices—conduit cages and Fibergraft—used together in spine surgery for people with degenerative disc disease or herniated discs. The cages help restore space between vertebrae, while Fibergraft is designed to support natural bone healing. Researchers will follow 100 patients for two years to see how well the spine fuses and track any complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: conduit cages and Fibergraft BG Putty (medical devices)
What this could lead to: If successful, this could show that combining these devices improves spine fusion rates and reduces complications after surgery.
What could go wrong: This is a small, early study without a comparison group, so results may not apply to everyone. Risks include typical surgery complications like infection or implant failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Intervertebral Disc Displacement intervertebral disk degenerative disorder lumbar disk degenerative disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEGENERATIVE DISC DISEASE HERNIATED DISC

Contacts and locations

Locations

University of Pittsburgh Medical Center
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.